Autoantibodies to desmoplakin I and II in patients with erythema multiforme by unknown
Autoantibodies  to Desmoplakin  I and II in Patients 
with Erythema  Multiforme 
By Dagmar Foedinger, Grant J. Anhalt,~ Barbara Boecskoer, 
Adelheid Elbe,* Klaus Wolff, and Klemens Rappersberger 
From the Department of Dermatology, Division of General Dermatology and the  *Division of 
Immunology,  Allergy and Infectious Diseases, Vienna International Research Cooperation 
Center, University of Vienna Medical School, A-f090  Vienna, Austria; and the CDepartment of 
Dermatology, Division of Dermatoimmunotogy, Johns Hopkins University, Baltimore, Maryland 
21205 
Sllll'Riillary 
Erythema multfforme (EM) represents a syndrome of chronic recurrent inflammatory skin disease. 
Depending on the severity and extent of skin and mucosal involvement,  it is defined either as 
EM minor or EM major.  In this study we demonstrate the presence of autoantibodies  (aAbs) 
against desmoplakin I and II, two major proteins of the desmosomal plaque, in six of six patients 
with the severe variant of EM, EM major. Light microscopic studies of lesional skin and mucous 
membranes localized in vivo bound immunoglobulin G (IgG) in a dotted desmosomal pattern 
along the cytoplasmic membranes of keratinocytes. By immunoelectronmicroscopy, in vivo bound 
IgG  was  confined  to  the desmosomal  plaques.  These findings  were confirmed by indirect 
immunolocalization studies that demonstrated the presence of IgG aAbs in the serum of patients 
during active disease. These aAbs did not only bind to desmosomal plaques of epithelial cells 
where they colocalized with defined murine monodonal antibodies directed against desmoplakin 
I and II, but also labeled the intercalated discs of myocardial cells. Biochemical characterization 
of circulating IgG aAbs revealed desmoplakin  I and II as actual target autoantigens.  By passive 
transfer of serum into newborn mice, in vivo binding of serum aAbs to keratinocytes was shown. 
The findings presented in this study imply a humoral immune response in certain patients with 
EM major and indicate a potential pathogenetic role of aAbs against desmoplakin  I and II in 
this disease. 
utoantibodies (aAbs) 1 play a crudal role in the patho- 
genesis of autoimmune bullous diseases such as pem- 
phigus vulgaris, pemphigus foliaceus, and buUous pemphigoid 
(1, 2). The target autoantigens  of pemphigus vulgaris and 
foliaceus are members of the family of desmosomal cadherins, 
transmembrane glycoproteins that mediate cell-to-ceU adhe- 
sion (3-5). In bullous pemphigoid, two distinct antigens have 
been characterized  (6,  7), of which the 230-kD protein is 
localized within the hemidesmosomal plaque of basal ker- 
atinocytes (8). This polypeptide shows extensive sequence ho- 
mologies with desmoplakin I and II, two major constitutive 
proteins of the desmosomal plaque (9-12).  Desmoplakin I 
and II have also been identified as components of the anti- 
genic complex characteristic of a recently described bullous 
autoimmune disease designated  paraneoplastic  pemphigus 
(13, 14). 
Erythema multiforme (EM) represents a syndrome of inflam- 
matory skin  eruptions with a broad spectrum  of clinical 
1Abbreviations used in  this paper: aAb,  autoantibody;  EM,  erythema 
multiforme; IF, immunofluorescence. 
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manifestations (15). Usually it runs an acute, self-limited, fre- 
quently recurrent course characterized by irislike erythemas 
and papules termed target lesions. This type of disease is desig- 
nated EM minor. However, certain patients with EM, in ad- 
dition to  target lesions, develop widespread  tense blisters 
and extensive erosions  of the oro-genital mucosa  and are 
thus dassified as EM major (15). Histopathology characteristi- 
cally demonstrates single cell death of keratinocytes evolving 
to focal necrosis of the entire epidermis,  a dense mononu- 
clear infiltrate  with a pronounced edema of the papillary 
dermis and subepidermal and very occasional intraepidermal 
blistering  (16). 
Previous studies have favored the concept that delayed-type 
hypersensitivity  reactions against various infectious agents (e.g., 
HSV and mycoplasma) and drugs (e.g., sulfonamides, peni- 
cillin derivatives, and phenytoin) (15, 17) trigger the inflam- 
matory cascade. Immunomorphological studies have suggested 
that the epidermal destruction observed in EM is mainly medi- 
ated by cytotoxic T  cells (18, 19). 
The widespread cutaneous blisters and extensive mucosal 
erosions of EM major patients often display striking similar- 
ities with the clinical features of patients with paraneoplastic 
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to search for humoral autoimmune phenomena in EM and 
to test the hypothesis whether humoral immune mechanisms 
contribute to the devastating condition of these patients. 
In this study we present immunomorphological and bio- 
chemical evidence that a distinct subset of EM patients, all 
clinically defined by severe involvement of the skin and mu- 
cous membranes,  develop  characteristic  aAbs  against des- 
moplakin I and II. This is only the second human disease 
in which aAbs against desmoplakins, major proteins of the 
adhesive  plaques of  desmosomes, have  been detected. Moreover, 
it is the only one in which there is evidence of binding by 
passive transfer and temporal correlation with disease activity. 
Our findings suggest that, in addition to T  cell-mediated 
pathophysiologic events operative in EM, humoral autoim- 
munity against the desmoplakins may play a crucial role in 
the pathogenesis of this life-threatening skin disease. 
Materials and Methods 
Patients 
14 patients with characteristic  cutaneous target lesions, who din- 
ically and histologically had been diagnosed as EM, entered the 
study. According to standard clinicopathological  criteria, eight pa- 
tients were classified  as EM minor; one of them showed iris lesions 
with extensive  blistering  without involvement  of the mucous mem- 
branes. Six patients, in addition to target lesions, had developed 
cutaneous blisters and extensive erosions of the oral and genital 
mucous membranes and were thus defined as EM major (15). Five 
of them had a history of several recurrences of the mucocutaneous 
disease, and one experienced the first episode. Extensive clinical 
and laboratory examination did not reveal the presence of a neo- 
plastic process in any of the patients. 
Tissues,  Sera,  and Antibodies 
Tissues.  Biopsy  specimens  of lesional and perLlesional  skin were 
available for immunomorphological  studies from aU patients, except 
one with EM minor. Normal human skin was obtained  from healthy 
volunteers. Biopsies were divided into three parts and processed 
for routine histopathology and immunofluorescence studies. For 
postembedding immunoclectrornicroscopy  (IEM) studies, specimens 
of lesional skin and of normal human skin were phced into PBS, 
pH 7.4, and chopped into pieces of ,~0.5-1.0 mm  3, immersed in 
2.3 M sucrose in PBS for 20 min, then mounted on pins, frozen, 
and stored in liquid nitrogen until further use. BALB/c  mice were 
killed by cervical dislocation, and tongue, liver, and myocardium 
were e~"ised,  snap frozen, and stored at -70~  Sections  of  monkey 
esophagus were purchased from INOVA (San Diego, CA). 
Sera.  Serum samples were obtained from all 14 patients on sev- 
eral occasions, during active disease and within phases of remis- 
sion. Blister fluid was obtained from one patient with EM major. 
We processed sera of patients with pemphigus vulgaris (3), pem- 
phigus foliaceus (1), paraneoplastic pemphigus (1), bullous pem- 
phigoid (4), toxic epidermal necrolysis (2), and sera of 10 healthy 
volunteers as controls. 
Antibodies.  Mouse  mAb to desmoplakin I and II (desmosomal 
plaque [dp] 2.15) and a mouse anti-keratin 1, 10/11 mAb were pur- 
chased from Progen (Heidelberg, Germany).  As second-step  reagents 
for immunofluorescence  (IF) microscopy,  we used affinity-purified 
FITC-conjugated goat F(ab')2 anti-human IgG, FITC-conjugated 
affinity-purified  anti-human IgM (all from Cappel, West Chester, 
PA), and FITC-conjugated rabbit anti-mouse  IgG (Jaxell, San 
Diego, CA). For double labeling purposes, TRITC (tetramethyl- 
rhodamine isothiocyanate)-conjugated  goat F(ab')2 anti-mouse lgG 
(Jaxdl) was used. IEM was performed with goat anti-mouse IgG 
conjugated to either 10 nm or  -  for double labeling  experiments- 5 
nm coUoid gold particles and goat anti-human IgG conjugated 
to colloidal  gold with a particle size of 10 nm (Amersham Interna- 
tional, Amersham, Bucks, UK). For immunoblotting we used alka- 
line phosphatase-conjugated  goat anti-human and goat anti-mouse 
IgG as detector antibodies (Promega Corp., Madison, WI). 
Light Microscopic and  Ultrastructural  Immunomorphology 
Direct and Indirect IF.  In accordance with routine methods (5), 
5-/~m cryostat sections of lesional and perilesional skin as well as 
from mouse tongue, liver, myocardium and urinary bladder, and 
monkey esophagus were preiucubated in PBS, pH 7.4, with 1% 
BSA (Serva, Heidelberg, Germany). Thereafter, the specimens  were 
exposed to FITC-conjugated goat F(ab')2 anti-human IgG and 
IgM diluted 1:100 in PBS, or, for indirect IF, to sera of  EM patients 
diluted 1:20. For control purposes, sera of  patients with pemphigus 
vulgaris, toxic epidermal necrolysis  and sera of healthy volunteers 
(all diluted 1:20 in PBS), as well as a mAb directed against des- 
moplakin I and II, diluted 1:80 in PBS, were used. 
Double Labeling IF on Cultured Human Keratinocytes.  For com- 
parative immunolocalization  studies,  double hbeling IF experiments 
were performed on cultured human keratinocytes.  Normal human 
keratinocytes obtained from surgically removed skin were grown 
to confluence  in chamber slides (LabTek; Nuuc, Naperville, IL) in 
keratinocyte growth medium (Clonetics Corp., San Diego, CA) 
at low calcium  concentration  (0.33 raM). These  cells  and cells  grown 
for 12 h after a switch to high calcium concentration (1.2 raM), 
which allows the maturation of desmosomes (20, 21), were washed, 
permeabilized with PBS containing 0.01% saponin (Sigma Chem- 
ical Co., St. Louis, MO) and 0.1% sodium azide at pH 7.4, and 
subsequently incubated with the serum samples of EM patients 
and the mAb dp 2.15. Bound immunoreactants were visualized 
with FITC-conjugated goat F(ab')~ anti-human IgG and TRITC- 
conjugated goat anti-mouse IgG. After final washing, cells were 
embedded in Fluoprep (BioMerieux, Marcy  l'Etoile, France) and 
coverslipped. 
IEM 
Direct IEM.  Direct IEM was performed on ultrathin cryosec- 
tions of the lesional skin of three patients to determine the ultra- 
structural localization of in vivo bound IgG. 
Indirect IEM.  The ultrastructural binding sites of circulating 
human nabs and murine mAb dp 2.15 were demonstrated  on normal 
human skin. 
Preparation of Tissue.  We followed methods routinely used in 
our laboratory (5, 22). To reduce nonspecific  binding, the speci- 
mens were first incubated in PBS/50 mM glycine  (Bio-Rad  Labora- 
tories, Richmond, CA)/10%  FCS (GIBCO-BRL, Gaithersburg, 
MD), and after 10 rain transferred with forceps to 7-10 #1 droplets 
of  the immunoreagents.  For direct IEM, the sections  were incubated 
with goat anti-human  IgG conjugated to 10 nm colloidal gold 
particles, diluted 1:10 in PBS/10% FCS for 30 min at room tem- 
perature (RT). For indirect IEM, the specimens were incubated 
with the mAb dp 2.15, diluted 1:100 in PBS/50 mM glycine/5% 
FCS, and/or the sera of  five  different  patients with EM major, diluted 
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after, the sections were rinsed six times for 5 min in PBS and then 
incubated on small drops of the immunoguld  reagent diluted 1:10 
in PBS/10%  FCS. Unbound immunoreagents  were removed by 
washing in PBS for 15 rain with three changes of buffer. In double- 
labeling experiments, we first demonstrated  the binding  sites of 
human aAbs by goat anti-human IgG, conjugated to 10 nm col- 
loidal gold particles. The sections were incubated in PBS/10% FCS 
for 15 rain and then consecutively exposed to the mouse mAb dp 
2.15 and to the goat anti-mouse IgG conjugated  to 5 nm gold 
particles. Some sections were incubated in goat anti-mouse IgG 
conjugated to 10 nm coUoidal gold particles as controls for direct 
IEM studies. Sections obtained from shave  biopsies of healthy volun- 
teers processed exactly as described above, also served as controls. 
We used sera of healthy volunteers and sera of patients with pem- 
phigus foliacens and isotype-matched mutine anti-keratin 1, 10/11 
antibody as controls  for indirect immunolocalization  studies. 
Biochemical Methods 
Immunoblotting of  Lysates of  Epiderraal Sheets.  Keratomed split- 
thickness skin was placed dermal side down in a 1 M sodium chlo- 
ride (Merck, Darmstadt,  Germany)/PBS solution for 12 h at 4~ 
Epidermal sheets were peeled from the dermis and homogenized 
in 2% SDS (BioRad Laboratories) in 0.0625 M tris-buffered saline 
(TBS), pH 6.8, supplemented with 5% 2-ME (Bio-Rad Laborato- 
ties) and 2 mM PMSF (Sigma Chemical Co.) using a motor-driven 
Teflon type Potter Elvejem homogenizer  (Kontes, Vineland, NJ). 
After boiling and centrifugation,  the supernatant was loaded onto 
7% SDS-PAGE slab-gels (23). Separated proteins were electropho- 
retically  transferred  to nitrocellulose  membranes  (Schhicher  & 
Schuell, Dassel, Germany) (24). Under highly stringent conditions, 
strips of the blotted epidermal proteins were blocked, incubated 
with patients' sera and the mAb, washed, and then incubated with 
alkaline phosphatase-conjugated  anti-mouse IgG or anti-human 
IgG, respectively. The enzyme reaction was visualized by nitrob- 
luetetrazolium/bromochloroindolyl  phosphatase  (Kirkegaard  & 
Perry Laboratories Inc., Gaithersburg,  MD) (25). 
Immunoprecipitation  of  Protein Lysates of Cultured Human Keratino- 
cytes.  Immunoprecipitation was performed according to the tech- 
nique described by Stanley et al. (26, 27). Human foreskin ker- 
atinocytes  grown  to  near confluence  as  described  above were 
incubated overnight with Ct4-1abeled amino acids (New England 
Nuclear, Boston, MA). Cells were extracted in 1% NP-40 (Calbio- 
chem-Novabiochem, La Jolla, CA) in TBS with 2 mM PMSF and 
proteinase inhibitors at a concentration  of 5 mM (Antipain,  Leu- 
peptin,  and  Chymostatin;  all  from  Calbiochem-Novabiochem 
Corp.). A particle-free supernatant was prepared by centrifugation 
of the cell extracts at 100,000 g for I h. Labeled extracts were se- 
quentiaUy preabsorbed with  normal  human  serum  and protein 
A-bearing,staphylococci (Pierce, Rockford, IL) and then incubated 
with the sera of all EM patients and human  controls  as well as 
mAb dp 2.15 for 1 h at 4~  Thereafter, antigen-antibody com- 
plexes were precipitated with staphylococcal protein G-Sepharose 
(Sigma Chemical Co.) and separated by SDS-PAGE, using 5% slab- 
gels. The precipitated antigens were visualized by autoradiography. 
In addition, to confirm the identity of the 210- and 250.kD bands 
with desmoplakin I and II, 1 ml aliquots of the lysate was preab- 
sorbed with 25 and 75 #g of the mAb dp 2.15 each, followed by 
precipitation with staphylococcal protein G-Sepharose to deplete 
them from desmoplakin I and II. Consecutively, these lysates were 
incubated with the sera of EM major patients and further processed 
as described above. 
Passive Transfer of Serum 
To examine whether human aAbs react with epidermal cells in 
vivo, we performed passive transfers of human serum into neonatal 
mice according to a modified method of Anhalt et al. (28). Serum 
of two patients  of this study, and for control,  of a patient  with 
pemphigus vulgaris and of a healthy volunteer were heated to inac- 
tivate complement  components.  100/~1 serum  was injected in- 
traperitoneally or subcutaneously into six 24-h-old BALB/c mice. 
18 h later, the mice were killed and tissue of the skin, tongue, liver, 
and myocardium was obtained for further histopathologic and IF 
studies. 
Results 
Light Microscopic and Ultrastructural Immunomorpholog? 
Demonstration of  In Vivo Bound aAbs in EM Patient~  Direct 
IF studies revealed the presence of in vivo bound IgG restricted 
to the epidermis of lesional skin in all six patients with EM 
major and in one with severe EM minor. At low magnification, 
dense deposits of IgG were found which appeared in an in- 
terceUular staining pattern not unlike that seen in pemphigus 
vulgaris (29).  The most intense labeling was found within 
the spinous cell layer, but sporadically, IgG binding was also 
seen within the basal and granular  cell layer, including the 
transitional cell layer. At higher magnification, in vivo bound 
IgG could be clearly confined to the plasma membranes of 
individual keratinocytes (Fig.  1 A). Moreover, depending on 
the plane of sectioning,  the labeling resolved into distinct 
fluorescent dots,  suggestive of a desmosomal staining pat- 
tern. Occasionally, we observed that the intercellular spaces 
separating IgG-positive keratinocytes were clearly devoid of 
Ig deposits,  indicative  of an  exclusive binding  of the im- 
munoreactants to the cell membrane or to intracellular struc- 
tures associated with epithelial cell membranes, i.e., desmo- 
somal plaques. As previously described by other investigators 
(17, 30), IgM deposits were observed along the dermo-epi- 
dermal junction in all patients with EM major and in four 
(out of nine) patients with EM minor; in contrast to in vivo 
bound IgG, these IgM deposits were not restricted to lesional 
skin, but were also found in perihsional skin. IgM together 
with complement  C3 was observed in perilesional and le- 
sional skin around the blood vessels of the papillary dermis 
in all EM patients. 
Direct IEM was performed to investigate the ultrastruc- 
rural localization of in vivo bound IgG in lesional skin.  10 nm 
colloidal gold particles indicating  in vivo bound IgG were 
detected in keratinocytes, exclusively.  The vast majority of 
the gold particles was associated with the desmosomal plaques 
(Fig.  1, B and C), where keratin filaments assemble with the 
desmosome (12). Another notable morphological finding was 
the detachment  of keratin  filaments  from the desmosomal 
plaques as has been previously described (31). These filaments 
formed an irregular  meshwork of filament bundles and clumps 
within the cytoplasm (not shown). However, the desmosomes 
morphologically appeared well preserved, and neither split- 
ting within the desmosomal glea nor true loss of cell adhe- 
sion, acantholysis, was observed. We never saw gold parti- 
cles within the intercellular spaces, or along the outer sheet 
171  Foedinger  et al. Figure  1.  Demonstration of in vivo bound IgG by direct immunofluorescence (A) and direct immunoelectronmicroscopy  (B and (2). A 5-/~m cryostat 
section of lesional skin from a patient  with EM major was incubated with  FITC-conjugated  goat F(ab')2 anti-human IgG (A).  Note the punctate 
desmosomal staining pattern  of the cell membranes  of keratinocytes (arrows). Occasionally, one clearly observes that  the intracdluhr  spaces appear 
devoid of IgG deposits (arrowhead). (B and C) Labeling of a 100-nm ultrathin  cryostat  section of lesional skin from a patient  with EM major with 
goat anti-human IgG conjugated  to 10 nm colloidal gold particles. The gold particles indicating  in vivo bound IgG are ~clusively  localized to the 
cytoplasmic desmosomal plaques (dp). Other portions  of the cell membrane  (m), the intercelhlar  spaces, especially the desmoglea (dg),  and keratin 
filaments are devoid of IgG deposits (C).  xS00 (A);  (D) Desmosome,  x30,000 (B); x70,000 (C).  Bars: 20/*m (A);  0.2/zm (B and C). 
of the cell membranes of keratinocytes. In addition, we con- 
sistently failed to demonstrate IgG deposits along the dermo- 
epidermal junction by IEM. 
As  control,  skin  of healthy volunteers was  processed. 
Normal human skin did not exhibit any binding of gold par- 
tides at specific sites. 
Localization of Antigens Recognized by Circulating aAbs of 
EM Patients in Epitkelial and Non~ithelial  Tissue.  The pres- 
ence of circulating aAbs in patients with EM was determined 
by processing several epithelial and nonepithelial tissues for 
indirect IF. Sera of six (out of six) of the EM major patients 
and none of eight EM minor patients contained aAbs recog- 
nizing antigens in the substrates  tested. In normal human 
skin staining was restricted to epidermal keratinocytes.  The 
labeling was confined to the plasma membrane of keratino- 
cytes throughout the entire epidermis (Fig. 2 A) and at higher 
magnification, the continuous labeling of the cell membranes 
resolved into a peculiar punctate fluorescent pattern, typical 
of desmosomal staining.  This distinct desmosomal staining 
pattern was most clearly evident along the basolateral mem- 
branes of basal keratinocytes. A labeling of hemidesmosomes 
was never observed. Moreover, this characteristic desmosomal 
staining pattern was consistently seen in all the stratified epi- 
thelial  tissues  of different species tested,  such  as  monkey 
esophagus and mouse tongue (Fig. 2, B and C). Similarly, 
in mouse liver, labeling was found at adhesion sites of hepa- 
tocytes (Fig. 2 E) and along the bile canaliculi. Epithdial cells 
of complex epithelia such as mouse urinary bladder revealed 
a surface staining (Fig.  2 D); in addition, this latter tissue 
also showed a delicate labeling along the basement membrane 
zone. It remains to be clarified whether this reactivity rep- 
resents labeling of hemidesmosomes  or other not yet defined 
structures of urinary bladder basement membrane. Examina- 
tion of mouse myocardium, tissue of mesenchymal origin, 
showed a strong labeling of the intercalated discs (Fig. 2 F), 
adhesive structures that are known to contain desmoplakin 
(32). Staining patterns achieved  with human EM major serum 
and with mAb dp 2.15 did not demonstrate essential differ- 
ences on any of the diverse substrates processed,  suggesting 
that the aAbs indeed bind to desmosomal  plaques and similar 
adhesive structures in mesenchymal tissue. 
Indirect IEM.  The exact ultrastructural localization of the 
antigen(s) recognized by the circulating aAbs was further de- 
termined by postembedding immunogold IEM studies on 
ultrathin cryosections of normal human skin. The major ad- 
vantage of this method is that the entire surface of the sections 
including all parts of the desmosome are accessible to anti- 
bodies. The electron-dense cytoplasmic desmosomal plaque, 
with the keratin filaments assembling at its inner surface, was 
clearly defined. The ultrastructural binding sites of the mAb 
dp 2.15 and the serum antibodies from the patients with EM 
major could be clearly localized to the cytoplasmic portion 
of the desmosomal plaque (Fig. 3, A  and B). By double im- 
munogold labeling with serum of patient 1 and the mAb 
against desmoplakin I and II, a colocalization of desmoplakin 
and the antigens recognized by the circulating aAbs  was 
confirmed (Fig.  3 D).  In contrast,  labeling with isotype- 
matched mAb against  keratin 1,  10/11  revealed a distinct 
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patients on various epithelial tissues and mouse myocardium.  Note the dotted desmosomal membrane staining of keratinocytes,  especially in the basal 
and suprabasal cell layers of normal human skin (A), monkey esophagus (B), and mouse tongue (C). A more continuous staining of the cell membranes 
is seen in the upper cell layers. The urothelial cells of mouse urinary bladder show a membrane staining in both cell layers (D). The hepatocytes  of 
mouse liver display distinct labeling of the cell membranes  at the junctional sites (E). In mouse myocardium, the labeling is confined to the intercalated 
discs (F). (Arrowheads)  Substrate-specific binding of immunoreactants,  x300; bars,  all 20/~m. 
173  Foedinger et al. Figure  3.  Ultrastructural  im- 
munoiocalization studies  on ultra- 
thin  cryosections  of  normal  hu- 
man skin. Binding of human nabs 
against desmoplakin I and II is in- 
dicated by lO-nm colloidalgold  par- 
tides conjugated  to goat anti-hu- 
man IgG (B and D). Labeling with 
a marine mAb to desmopla/dn I and 
II dp 2.15  is  demonstrated  with 
10-nm gold particles in A and with 
5 nm gold lXa'ticles  in D. The mAb 
and  the  human  aAbs  exclusively 
bind to  the  inner  portion  of the 
e~t~a-&u.~ &smo~ma/plaque 
(A and/3). Double labding experi- 
ments dearly reveal a co|o~ii~tion 
of both.  the m.Ab dp 2.15 (S-rim 
gold lm~:__l~_,  ahoy0 and the serum 
nabs  (10-nm gold  particles);  (D). 
The desmoglea and the keratin fila- 
ments are devoid  of immtmoreac- 
tams.  In  contrast,  binding  of  a 
mouse  monoclonal  anti-keratin 
1, 10/11 antibody is confined to the 
intermediate  size filaments as dem- 
onstrated by 10-nm gold particles 
i.e. (as)  r~mogl~ (B); ￿ 
(A-C), x200,000 (D). Ban0.1/~m. 
labeling of intermediate  size filaments  (Fig. 3 C) but not of 
desmosomal plaques.  Normal human serum did not show 
any labeling. 
Desmosomal IF Staining Battem on Cultured Human Keratino- 
teS.  Double labeling immunolocalization studies were per- 
rmed  with serum  from all patients  with EM  major and 
the murine mAb dp 2.15 on cultured human keratinocytes. 
To do so we processed monolayers  of human keratinocytes 
grown at low calcium concentration and cells  12 h after a 
shift to high calcium concentration. Only after a gentle per- 
meabflization of cells with saponin could staining be achieved 
with both the human serum samples  and the raAb.  Cells 
at low caldum displayed an irregularly distributed  punctate 
staining pattern throughout the entire cytoplasm. Cel/s grown 
in high calcium showed bright fluorescent dots along their 
cytoplasmic membranes, especially at adhmon rites with neigh- 
boring ~  that dearly colocalized in double labeling 
experiments  (Fig.  4, A  and B)  (14,  33). 
Biochemical Characterization of nAbs of EM Major Patients 
Immunoblotting.  The specificity  of human aAbs  against 
desmosomal structures was examined by immunoblotting of 
epidermal lysates. The aAbs present in the sera of EM major 
patients  were reacted with the dectrophoretically separated 
proteins  of epidermal extracts.  Sera of all six patients  with 
EM major but none of the eight patients with EM minor 
bound to polypeptides of 250 and of 210 kD (Fig. 5, lanes 
3-8). These two polypeptides  precisely corn/grated with des- 
Figttrt  4.  Double immunofluo- 
re~mce ~  of  o.tlmr~ human 
keratinecytes  grown  in  high  cal- 
cium. Ce~ were gently permeabi- 
lined  with  saponin  and incubated 
with re'am of an EM major patient 
(A) and the mAb to desmoplakin 
1 and iI (/~. Bound antibodies were 
vima~ by Frrc-coaj~ anti- 
htama  I~ and  TILrrGconjagated 
aafi--mome  I~. Both  reactants  dis- 
play a distinct dotted staining of the 
cytophsmic membranes of cultured 
human keratinocyte~ Note the dom- 
inant staining and colocalization of 
serum nabs and mAb dp 2.15 at the 
binding sites  of neighboring  ker- 
atinocytes  (arrowheads).  ￿  bar 
20 p.m. 
174  Autoantibodies  to Desmoplakins in  Erythema Multiforme Figure  5.  Immunoblotting. Lysates of normal human epidermis were 
separated by SDS-PAGE, transferred to nitrocellulose,  and reacted with 
sen of EM major patients (lanes 3-8), and the mAb dp 2.15 (lane 2). Human 
aAbs of all EM major patients (lanes 3-8) bind to polypeptides of 250- 
and 210-kD  molecular mass, that comigrate with desmoplakin I and II 
(lane 2). As controls, labeling with serum of a patient with bullous pem- 
phigoid (230-kD band in lane 9) and normal human serum (lane 10) is 
shown.  Molecular weight standard indicates  200 kD (lane  I). 
moplakin I and II as demonstrated by staining  with mAb 
dp2.15 (Fig. 5, lane 2). Additional controls with ser~ of 10 
healthy  volunteers  and two patients  with toxic  epidermal 
necrolysis did not stain any specific band. Serum samples of 
two patients  with EM major were obtained 9 mo after the 
last EM episode. Interestingly,  after processing these sera in 
dilution identical to that present during active disease (1:500), 
no specific labeling  of epidermal extracts was found. 
Immunoprecipitation.  Immtmoprecipltation  studies of C 14- 
labded human keratinocytes demonstrated the presence of 
aAbs in the sexa office (out of six) EM major patients, whereas 
the sera of all EM minor patients were devoid of precipitating 
IgG. These aAbs precipitated two polypeptides  of 250 and 
210 kD (Fig. 6, lanes 5, 8-II), that precisely comigrated with 
desmoplakin  I (250 kD) and desmoplakin II (210 kD), as 
indicated by predpitation with the mAb dp 2.15 (Fig. 6, lane 
4). In addition, blister fluid of one patient precipitated the 
identical  complex of polypeptides  (Fig.  6,  lane 6).  These 
findings were further confirmed by processing  a serum of 
a patient with paraneoplastic pemphigus, which revealed the 
presence of aAbs against the characte0.'stic antigen complex 
(250 kD/230 kD/210 kD/190 kD/170 kD) (Fig. 6, lane 2). 
The identity of the 210 and 250-kD bands with desmoplakin 
I and II was additionally confirmed by a consecutive immu- 
noprecipitation  of the lysates with the mAb dp 2.15 and the 
patients' sera. Preabsorption of the lysates with mAb dp 2.15 
strongly reduced the reactivity with serum aAbs (Fig. 6, lane 
13)  and  even completely depleted  the  autoantigens  (des- 
moplakin I and II) from the lysate (Fig. 6, lane 14). Serum 
samples of two patients with EM major obtained 9 mo after 
the last EM recurrence failed to precipitate any specific band 
(Fig. 6, lane 7). We also consistently failed to detect circulating 
aAbs in all patients with EM minor and healthy volunteers 
(Fig. 6, lane I2),  whereas serum of a patient with buUous 
pemphigoid precipitated  the characteristic  polypeptide  of 
230 kD (Fig.  6, lane 3). 
Passive ~ansfer of Serum 
A slight  erythema was observed at the sites of subcuta- 
neous injection of biochemically  characterized serum of two 
patients with EM major into newborn mice, 18 h after injec- 
tion. Skin biopsies did not display any histopathological fea- 
tures of EM. However, by direct  IF an intense labeling of 
Figure 6.  Immunoprecipitation. 
Immtmoprecipitation  of  protein ex- 
tracts of radiohbeled cultured hu- 
man keratinocytes with sera of EM 
major patients 1-5 (lanes 5, 7, 8-11) 
and blister fluid of patient 1 (lane 
6). All sera and the blister fluid pre- 
dpitate two major bands of 250- and 
210-kD molecular weight. Bands of 
identical mobility  were precipitated 
by the murine mAb to desmoplakin 
I  (250 kD) and II (210 kD) (lane 
4). A serum sample obtained from 
an  EM major patient 9  mo after 
the last clinical eruption (lane  7), 
as well as serum samples from a healthy volunteer (lane 12) failed to immunoprecipitate any specific polypeptide. Lane 2 represents  the characteristic 
antigen complex precipitated by serum of a patient with paraneoplastic  pemphigus and lane 3 shows  the precipitation of the 230-kD antigen with 
serum of a bullous pemphigoid patient. (Lane 1) Molecular weight standard indicating 200 kD. Asterisks mark from the top to bottom: 250,  230, 
210, 190, and 170 kD. Preabsorbing the lysates with the mAb dp 2.15 in a concentration of 25 ~g/1 ml lysate strongly reduced  the reactivity with 
serum aAbs (lane 13), and higher concentration of mAb dp 2.15 (75 ~g/1 ml lysate) almost completely depleted the autoantigen (lane 14) (same serum 
as shown in lane 8). 
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detected (Fig.  7, top).  These IgG deposits labded the cyto- 
plasmic membranes of mouse keratinocytes, and occasionally, 
this staining pattern was reminiscent of cytoplasmic labeling. 
A ddicate punctate labeling was seen after subcutaneous and 
intraperitoneal injection of pemphigus vulgaris serum (Fig. 
7,  bottom).  We consistently failed to demonstrate in vivo 
deposits of human IgG in the murine epidermis after  in- 
traperitoneal injection of the serum of EM major patients. 
In addition, other murine tissues such as tongue, liver, and 
myocardium were also devoid of in vivo bound human anti- 
bodies. Injection of control sera of healthy volunteers consis- 
tently yielded negative results by direct IF (Fig.  7,  middle). 
Figure  7.  Antibody  binding after passive transfer of serum from an EM 
major patient into newborn BALB/c mice. 18 h after subcutaneous  injec- 
tion  direct  immunofluoresence  using  FITC-conjugated goat  F  (ab')2 
anti-human IgG revealed in vivo-bound human IgG decorating the cyto- 
plasmic membranes  of murine epidermal keratinocytes  (arrowheads,  top). 
Most intense labeling was detected  within the basal and suprabasal cell 
layers  overlying the sites of injection. As control, injection of normal human 
serum did not result in intraepidermal IgG deposits (middk). Passive  transfer 
of a serum from a patient with pemphigus vulgaris leads to the character- 
istic staining of the intercdhlar spaces (arrowheads,  bottom). (Amavs) Basal 
membrane zone.  x300,  bar 20/~m. 
Discussion 
In this study we provide immunomorphological  and bio- 
chemical evidence for the presence of circulating IgG (IgG1 
and IgG4) aAbs to desmoplakin I  and II in patients with 
EM major but not in patients with the minor variant of this 
disease and not in control sera of healthy volunteers.  Direct 
IF studies of lesional and clinically uninvolved skin revealed 
in vivo bound IgG along the cell membranes of keratino- 
cytes oflesional skin. On the other hand, when normal human 
skin of healthy volunteers was incubated with the serum of 
such patients, indirect IF revealed a similar staining pattern 
of the cytoplasmic membranes of keratinocyte~ This suggested 
the presence of circulating serum aAb that bind to epidermal 
proteins.  Moreover,  at the light microscopic level these im- 
munoreactants were distributed in a punctate pattern along 
the cell membranes of keratinocytes  indicating a binding to 
desmosomes, major structures of cell adhesion. To prove the 
validity of this assumption, several  epithelial and mesenchymal 
tissues that contain desmosomes and desmosomal proteins 
such as mouse tongue, liver, bladder,  and myocardium, as 
well as monkey esophagus, were labeled with the sera of pa- 
tients and, for comparison, with a mAb directed against the 
defined desmosomal  proteins desmoplakin I and II. Both, pa- 
tients' sera and mAb revealed a dearcut punctate, desmosomal 
staining pattern of epithelial cells from tongue and esophagus, 
as well as hepatocytes,  and the intercalated  discs of mouse 
myocardium, a tissue of mesenchymal origin that contains 
desmoplakins (32). 
Biochemical studies support our hypothesis that circulating 
aAbs of patients with EM major actually bind to desmoplakin 
I and II and not to any other desmosomal/cytoplasmic  pro- 
tein. By immunoprecipitation of extracts of C14-1abeled hu- 
man keratinocytes two major bands of 250 and 210 kD were 
detected that precisely comigrated with desmoplakin I and 
II and Western blot experiments clearly showed a binding 
of serum aAbs to desmoplakin I and II. These experiments 
exclude the possibility that desmoplakins are simply coprecipi- 
tated with another protein but show that they are true targets 
of the aAbs. Because desmoplakin I and II are localized within 
the cytoplasm and do not have any extracellular/transmem- 
brane domains, the question arose whether they actually rep- 
resent in vivo binding sites. We have addressed this question 
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IgG is mostly confined to the innermost portions of the des- 
mosomal plaques which excludes the possibility that another 
not yet defined (homologous) protein with an extracellular 
localization is recognized by the aAbs. These findings are fur- 
ther corroborated by indirect ultrastructural immunolocali- 
zation studies with ultrathin cryosections of normal human 
skin which reveal that serum aAbs and mAbs against des- 
moplakin I and II colocalize to the desmosomal plaques. 
Taken together, these findings clearly show the presence 
of a new subtype of human aAbs that appears to be a charac- 
teristic feature of certain patients with EM major, and that 
obviously binds to a cytoplasmic antigen. The findings also 
indicate that a humoral immune response occurs in such pa- 
tients, not unlike that seen in patients with defined bullous 
autoimmune diseases. In the recent past, one of us (13, 14) 
has described a new mucocutaneous blistering  disease that 
occurs in association with certain internal neoplasms and that 
was therefore designated "paraneoplastic pemphigns'" Patients 
with paraneoplastic pemphigus develop aAbs against a char- 
acteristic subset of five different polypeptides  of 250, 230, 
210, 190, and 170 kD. The 250- and 210-kD polypeptides 
were identified as desmoplakin I and II and the 230-kD pro- 
tein as the bullous pemphigoid antigen I, whereas the 190- 
and 170-kD polypeptides still have to be characterized. All 
patients with EM major as defined in this study, who were 
shown-by several  laboratory examinations and extensive  rou- 
tine diagnostic  procedures-not to have a concurrent neo- 
plastic disorder, obviously develop aAbs against a distinct an- 
tigenic complex that consists of desmoplakin  I and II. 
Desmoplakins  are major constitutive proteins of desmo- 
somes that are exclusively  located intracellularly  and contribute, 
in part, to the formation of desmosomal plaques. Desmo- 
plakins consist of an or-helical  coiled  coil rod domain of 130-nm 
length with heptad repeats similar to the two chained coiled 
coil rod domains of all intermediate filaments. On either end 
of the rod there are globular subdomains. More recent mo- 
lecular investigations have  revealed that the COOH-terminal 
globular domain which includes three subdomains composed 
of series of 38-residue repeats, and which does not incorporate 
into the plaque, mediates the assembly of keratin filaments 
to the desmosomal plaque (12, 34, 35). Our observations by 
IEM that human aAbs to desmoplakin I and II bind to those 
portions of the desmosomal plaque, where keratin filaments 
assemble, open the attractive possibility  that they bind to 
the COOH-terminal domain and thus interfere with the as- 
sembly/adhesion of keratin filaments with desmosomes. This 
hypothesis is further strengthened by the ultrastrnctural ob- 
servation of a disassembly of keratin filaments from desmo- 
somes, by the subsequent dumping of filaments into an elec- 
tron-dense meshwork within the cytoplasm (31), and finally 
by the appearance of cytologic features similar to dyskera- 
tosis. In accordance with this are our ultrastructural studies 
that revealed  morphologically well preserved desmosomes also 
in pathologically affected keratinocytes, and this explains the 
complete absence  of true acantholysis. These observations may 
be seen in line with the findings of Klymkowsky et al. (36, 
37) who observed similar ultrastructural changes of inter- 
mediate filament clumping and persistence of desmosomes 
after microinjection  of mAb against keratin filaments into 
Ptk2-cells. They also indicate that neither the integration of 
desmoplakins into desmosomes nor the adhesive properties 
of these structures is involved in the pathogenetic events oper- 
ative in EM. Any speculation about a pathogenic role of aAbs 
against desmoplakins seems to be tempered by the fact that 
they are intracellular proteins. How should serum aAbs bind 
to and presumably compromise the function of such intra- 
cellular antigens? We addressed the question whether aAbs 
to desmoplakin I and II may play a role in the pathogenesis 
of EM in a set of experiments with cultured human keratino- 
cytes and neonatal mice. By IF cultured cells displayed  a clearcut 
desmosomal staining with EM sera and murine mAb to des- 
moplakin I and II after mild permeabilization with saponin. 
In addition,  subcutaneous injection of serum into neonatal 
BALB/c mice resulted in a binding of human IgG to mouse 
keratinocytes within the epidermis overlying the sites of in- 
jection, in a pattern similar to that of lesional skin of EM 
patients. However, after intraperitoneal injection we consis- 
tently failed to demonstrate in vivo bound IgG within the 
epidermis. These findings suggest that additional events, such 
as mild damage of keratinocytes as induced by permeabiliza- 
tion of cells in culture or edema by injection in vivo, are re- 
quired  to provide access of aAbs to the cytoplasm. 
Our findings have to be seen in context with previous in- 
vestigations on EM that have demonstrated a preponderance 
of cytotoxic T cells within the lesional epidermis (18, 19). 
One could further speculate that the infiltration of such cells 
into the epidermis may cause the damage that is required for 
desmoplakin I and II aAbs to gain access to and bind to their 
intracellular targets. Bound antibodies might then interfere 
with the assembly of keratin filaments with the desmosomal 
plaque resulting in a disassembly of keratin filaments, ker- 
atin filament clumping, single cell necrosis, and focal necrosis 
of the entire epidermis. Circumstantial  evidence that aAbs 
might be causally involved in the pathogenesis of EM major 
comes from the observation of circulating aAbs during the 
first disease episode in one patient.  Alternatively, it has to 
be considered that aAbs are only raised secondarily as a con- 
sequence ofT cell-mediated keratinocyte injury and that they 
are therefore not primarily involved in the pathogenesis of 
EM. At this time, therefore, we currently do not have con- 
vincing evidence that these aAbs contribute to the pathology 
of EM major. 
This study shows that aAbs directed to desmoplakin I and 
II characterize  and are possibly  involved  in epidermal pathology 
of EM major. This provides us with a new disease model 
with which we can further investigate how serum aAbs may 
gain access to, bind with, and compromise the function of 
important cytoplasmic epithelial adhesion molecules. 
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